Your browser doesn't support javascript.
loading
Characterization of chemical features of potent myeloperoxidase inhibitors.
Soubhye, Jalal; Meyer, Franck; Furtmüller, Paul; Obinger, Christian; Dufrasne, François; Antwerpen, Pierre Van.
Afiliação
  • Soubhye J; Laboratoire de Chimie Pharmaceutique Organique, Faculté de Pharmacie, Université Libre de Bruxelles, Brussels, Belgium.
  • Meyer F; Laboratory of Biopolymers & Supramolecular Nanomaterials, Faculty of Pharmacy, Université Libre de Bruxelles (ULB), Campus de la Plaine, Boulevard du Triomphe, 1050 Bruxelles, Belgium.
  • Furtmüller P; Department of Chemistry, BOKU-University of Natural Resources & Life Sciences, Vienna.
  • Obinger C; Department of Chemistry, BOKU-University of Natural Resources & Life Sciences, Vienna.
  • Dufrasne F; Laboratoire de Chimie Pharmaceutique Organique, Faculté de Pharmacie, Université Libre de Bruxelles, Brussels, Belgium.
  • Antwerpen PV; Laboratoire de Chimie Pharmaceutique Organique, Faculté de Pharmacie, Université Libre de Bruxelles, Brussels, Belgium.
Future Med Chem ; 8(11): 1163-77, 2016 07.
Article em En | MEDLINE | ID: mdl-27402298
BACKGROUND: Despite its important role in the immune system, myeloperoxidase (MPO) is implicated in a wide range of inflammatory syndromes due to its oxidative product HOCl. The oxidative damages caused by MPO make it a new target for developing promising anti-inflammatory agents. In this paper, we tried to understand the mechanism of MPO inhibition in order to facilitate the drug design, to develop more accurate virtual tests and to understand the structure-activity relationship. RESULTS: Based on docking experiments, kinetic studies and in vitro tests, it is determined that a potent MPO inhibitor must possess an oxidizable group in addition to a high affinity with the active site. At last, a new hit was found in this work namely 4-(3-hydroxy-phenoxy)-butylamine (5) that has IC50 of 86 nM. CONCLUSION: Hydroxy-phenoxy alkylamine derivatives were found to be promising MPO inhibitors and they may represent an important starting point in the development of more potent MPO inhibitors.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peroxidase / Inibidores Enzimáticos / Aminas Limite: Humans Idioma: En Revista: Future Med Chem Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Bélgica País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peroxidase / Inibidores Enzimáticos / Aminas Limite: Humans Idioma: En Revista: Future Med Chem Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Bélgica País de publicação: Reino Unido